Mastectomy pain study: which drug works best?
NCT ID NCT06974656
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study tested two drugs, dexmedetomidine and lidocaine, given during surgery to control pain after a mastectomy. 40 women took part. The goal was to see which drug delays the need for extra pain medicine and keeps vital signs stable.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- dexmedetomidine and lidocaine
- What this could lead to
- If one drug works better, it could offer a more effective way to control pain right after mastectomy, reducing the need for stronger painkillers.
- What could go wrong
- This is a small, early-stage trial with only 40 people, so results may not apply to everyone. Both drugs have known side effects like low blood pressure or heart rate changes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cairo University
Cairo, 12613, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- Can patients safely dispense their own pain medicine after surgery?
- Can a personalized exercise program boost recovery in cancer survivors?
- Smartwatch could spot nerve damage before it starts
- Can a VR headset calm nerves before surgery?
- Could ionized gas help fight breast cancer after surgery?